In the News

199 News Items found
Internist Francesca Gany is seen leaning on a taxicab and smiling. She leads the MSK Immigrant Health & Cancer Disparities Service, which this year marks its tenth anniversary
The MSK Immigrant Health & Cancer Disparities service improves people’s lives in communities that too often get overlooked and suffer disproportionately from cancer, including lack of access to care.
Marie-Josée Kravis Quantitative Biology Fellows Corey Weistuch and Sneha Mitra
Learn about the Marie-Josée Kravis Fellowship in Quantitative Biology, a two-year postdoctoral fellowship that aims to build a new generation of skilled quantitative biologists who specialize in cancer.
Two cancer researchers at the American Society of Clinical Oncology annual meeting
In the News
Couldn’t be at ASCO this year? Read highlights from the first half of the meeting.
Gerstner Sloan Kettering Students
Eight scientists are poised to receive their doctorates and embark on careers tackling problems in human disease through biomedical research. Their years of dedication and training will be recognized on May 18, 2022, when they will be awarded their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s commencement marks the school’s 11th graduating class since admitting its first students in 2006.
A researcher working in an MSK lab
New MSK research investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their 90s who underwent lung cancer surgery had positive outcomes; shares lessons on the responsible governance of artificial intelligence in oncology; studies AI-assisted biomarker assessment in lung cancer; and demonstrates a cancer-trained large language model has strong predictive value.
Carol Brown
Gynecologic surgeon Carol Brown shared information about cancer health equity during two expert panels in February.
Photo of a man, woman, and child sitting outside smiling
Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Luis Alberto Diaz Jr.
President Biden announced on September 15 his appointment of MSK medical oncologist and Head of the Division of Solid Tumor Oncology, Luis Alberto Diaz, Jr., MD, as one of seven distinguished members of the National Cancer Advisory Board.
The latest results come from a team of MSK physicians and scientists (from left to right): Bob Li, Hai-Yan Tu, Mackenzie Myers, Flavia Michelini, Emiliano Cocco, Sandra Misale, and Maurizio Scaltriti
In the Clinic
Results from a clinical trial and animal studies provide support for targeting the HER2 protein in multiple cancer types.
an illustration of cancer metastasis
In the News
Read our key takeaways from the second half of the American Association for Cancer Research’s 2019 annual meeting.